Inside Precision Medicine September 24, 2024
Daryl Pritchard, PhD

EDITOR’S NOTE: As a membership-based nonprofit institution dedicated to the advancement of personalized medicine, the Personalized Medicine Coalition (PMC) is working to encourage the clinical adoption of the tools and technologies that make personalized medicine possible. The appended update is designed to inform Inside Precision Medicine’s readers about the Coalition’s progress during the past two years.

As this magazine’s readers may know, on October 31, 2022, PMC and its partners from Diaceutics and Reservoir Communications published a landmark article in JCO Precision Oncology that documented the scope and complexity of clinical practice gaps in personalized medicine.

Twenty years after the completion of the Human Genome Project, this paper provided the first in-depth look at the efforts of United States health...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Pharma / Biotech, Precision Medicine
Bringing genomics closer to patients: 3 takeaways from Henry Ford Health
Oncologist talks personalized medicine for pancreatic cancer
AI offers a step above genomic solutions
How Mayo Clinic is using real-world data to advance precision medicine
Aignostics Secures $34 Million Series B to Enhance Precision Medicine with AI

Share This Article